04/17/2024
4:26 PM | Vanda Pharmaceuticals (Filer)
| Form 8-A12B | |
04/17/2024
4:19 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
3:32 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:31 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
3:48 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:50 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:06 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/04/2024
8:08 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
8:10 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
8:12 PM | Vanda Pharmaceuticals (Subject)
Wijkstrom Joakim (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
8:14 PM | Vanda Pharmaceuticals (Subject)
Williams Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:50 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:52 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:52 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:52 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:53 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:31 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K/A | |
02/13/2024
9:53 AM | RENAISSANCE TECHNOLOGIES LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
6:19 AM | Vanda Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
3:34 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
10:52 AM | BlackRock Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
10:26 AM | STATE STREET CORP (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/07/2023
4:19 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:04 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
08/23/2023
3:23 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
4:13 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
4:44 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023
3:30 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2023
3:34 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:02 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
7:29 PM | Vanda Pharmaceuticals (Subject)
Williams Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
3:17 PM | Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:18 PM | DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:19 PM | Honore Tage (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:19 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:20 PM | Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2023
11:15 PM | Vanda Pharmaceuticals (Filer)
| Form EFFECT | |
05/03/2023
3:55 PM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
